Contract Research & Services
Clinical Trials

Clinical Trials News

View news from other Pharmaceutical sectors:
31-45 of 4234 results
Regeneron’s eye-drug combination fails in two Phase 2 studies
By PBR Staff Writer
Regeneron Pharmaceuticals announced that results from two Phase 2 studies that added the angiopoietin2 (Ang2) antibody nesvacumab to EYLEA (aflibercept) Injection did not provide enough differentiation to warrant phase 3 development.
Contract Research & Services > Clinical Trials > News
ViiV Healthcare begins third phase III HIV trial of cabotegravir/rilpivirine regimen
ViiV Healthcare, a joint venture of GSK, Pfizer and Shionogi, has commenced a phase III study with a two-drug regimen of its long-acting, injectable cabotegravir and Janssen Sciences Ireland’s long-acting injectable rilpivirine in virally suppressed adults with HIV-1 infection.
Contract Research & Services > Clinical Trials > News
Cancer Research UK to use Astra Zeneca’s AZD1775 in head and neck cancer trial
By PBR Staff Writer
UK researchers are all set to launch an early-stage trial to evaluate an experimental drug from Astra Zeneca’s for improving the treatment of head and neck cancer.
Contract Research & Services > Clinical Trials > News
Cytokinetics’ ALS treatment tirasemtiv fails to meet primary endpoint in phase 3 study
Cytokinetics has announced that international phase 3 clinical trial of tirasemtiv in patients with amyotrophic lateral sclerosis (ALS) has did not meet the primary endpoint.
Contract Research & Services > Clinical Trials > News
Research finds gastric acid suppressant lansoprazole could target tuberculosis
By PBR Staff Writer
A new research in the UK suggests that a cheap and commonly used drug to treat heartburn, gastritis and ulcers has the potential to target Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB).
Contract Research & Services > Clinical Trials > News
European Prevention of Alzheimer’s Dementia Consortium opens six new study sites
The European Prevention of Alzheimer’s Dementia Consortium (EPAD) is enrolling research participants at six new sites, which takes the total to ten centers across six European countries.
Contract Research & Services > Clinical Trials > News
Summit completes initial dosing trials on Duchenne muscular dystrophy drug
By PBR Staff Writer
Summit Therapeutics has completed the half-way stage of dosing of its Duchenne Muscular Dystrophy (DMD) candidate ezutromid in a 48-week phase 2 trial, dubbed PhaseOut DMD.
Contract Research & Services > Clinical Trials > News
Arcus Biosciences secures funding to advance clinical programs for AB928
Clinical-stage biotechnology company Arcus Biosciences has completed a $107m series C financing, bringing the total equity capital to around $227m.
Contract Research & Services > Clinical Trials > News
Sage’s brexanolone meets primary endpoints in phase 3 postpartum depression trials
Sage Therapeutics has reported positive top-line results from two phase 3 clinical trials with its i.v. formulation of brexanolone (USAN; formerly SAGE-547); Study 202B in severe postpartum depression (PPD) and Study 202C in moderate PPD.
Contract Research & Services > Clinical Trials > News
Tricida announces closing of $57.5m series D financing
Tricida has closed an oversubscribed $57.5m series D financing, bringing the company’s total capital raised to-date to $153.3m.
Contract Research & Services > Clinical Trials > News
Novartis’ breast cancer drug Kisqali succeeds in phase 3 study in premenopausal women
By PBR Staff Writer
Novartis’ Kisqali (ribociclib) combination therapy has succeeded in a phase 3 study in premenopausal women with hormone-receptor positive, human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced or metastatic breast cancer.
Contract Research & Services > Clinical Trials > News
Boehringer says Cyltezo and Humira have similar efficacy, safety in people with RA
Boehringer Ingelheim has revealed one-year data from VOLTAIRE-RA, a pivotal phase 3 clinical trial evaluating Cyltezo (adalimumab-adbm) with reference product Humira.
Contract Research & Services > Clinical Trials > News
Trial finds blood plasma infusions could help treat Alzheimer’s
By PBR Staff Writer
A team of researchers in the US have found that regular infusions of blood plasma from young donors could well be a new treatment option for Alzheimer’s disease.
Contract Research & Services > Clinical Trials > News
Sanofi, Alnylam present positive complete results of patisiran from phase 3 study in hATTR amyloidosis patients with polyneuropathy
Sanofi Genzyme, and Alnylam Pharmaceuticals have reported positive complete results from the Apollo Phase 3 study of patisiran, an investigational RNAi therapeutic being developed for patients with hereditary ATTR (hATTR) amyloidosis with polyneuropathy.
Contract Research & Services > Clinical Trials > News
GSK study shows COPD 'superiority' for Anoro Ellipta versus Stiolto Respimat
By PBR Staff Writer
GlaxoSmithKline’s (GSK) study showed that Anoro Ellipta is more effective than Stiolto Respimat in improving lung function in patients with chronic obstructive pulmonary disease (COPD).
Contract Research & Services > Clinical Trials > News
31-45 of 4234 results